id	sid	eid	entity	type
dti-1410	1	1	29drug	CARDINAL
dti-1410	1	2	2015:9	CARDINAL
dti-1410	1	3	imai	ORG
dti-1410	1	4	tetsu akimoto	PERSON
dti-1410	1	5	chiharu ito	PERSON
dti-1410	1	6	takahiro masuda	PERSON
dti-1410	1	7	daisuke nagata division	PERSON
dti-1410	1	8	jichi medical university	ORG
dti-1410	1	9	tochigi	GPE
dti-1410	1	10	japan	GPE
dti-1410	2	1	abstr	PERSON
dti-1410	2	2	48-year-old	DATE
dti-1410	4	1	2	CARDINAL
dti-1410	7	1	imai et al	PERSON
dti-1410	8	1	2015:9 29–31 doi:10.4137	MONEY
dti-1410	9	1	july 13, 2015	DATE
dti-1410	10	1	september 10, 2015	DATE
dti-1410	11	1	september 14, 2015	DATE
dti-1410	12	1	anuj chauhan	PERSON
dti-1410	12	2	three	CARDINAL
dti-1410	13	1	358	CARDINAL
dti-1410	17	1	3.0	CARDINAL
dti-1410	21	1	third	ORDINAL
dti-1410	25	1	2	CARDINAL
dti-1410	25	2	2	CARDINAL
dti-1410	25	3	2	CARDINAL
dti-1410	26	1	48-year-old	DATE
dti-1410	27	1	the past four months	DATE
dti-1410	28	1	35 years of age	DATE
dti-1410	28	2	2	CARDINAL
dti-1410	28	3	9.4%	PERCENT
dti-1410	29	1	two months	DATE
dti-1410	29	2	7.1%	PERCENT
dti-1410	29	3	60 mg	QUANTITY
dti-1410	29	4	25 mg	QUANTITY
dti-1410	29	5	irbesartan	ORG
dti-1410	29	6	100 mg	QUANTITY
dti-1410	29	7	10 mg	QUANTITY
dti-1410	29	8	rosuvastatin	PERSON
dti-1410	29	9	2.5 mg	CARDINAL
dti-1410	33	1	153/87	CARDINAL
dti-1410	33	2	90	CARDINAL
dti-1410	33	3	36.0°	QUANTITY
dti-1410	34	1	98%	PERCENT
dti-1410	36	1	9.5	CARDINAL
dti-1410	36	2	33.6	CARDINAL
dti-1410	36	3	5.5	CARDINAL
dti-1410	36	4	14.5	CARDINAL
dti-1410	36	5	1.01	CARDINAL
dti-1410	36	6	141	CARDINAL
dti-1410	36	7	4.0	CARDINAL
dti-1410	36	8	105.1	CARDINAL
dti-1410	36	9	20	CARDINAL
dti-1410	36	10	9	CARDINAL
dti-1410	36	11	u/l	EVENT
dti-1410	36	12	180 mg	QUANTITY
dti-1410	36	13	6.6%	PERCENT
dti-1410	36	14	0.3 mg	QUANTITY
dti-1410	37	1	7.0	CARDINAL
dti-1410	37	2	24-hour	TIME
dti-1410	37	3	five to nine	CARDINAL
dti-1410	38	1	29.0 ml	QUANTITY
dti-1410	41	1	daily	DATE
dti-1410	42	1	year	DATE
dti-1410	42	2	2015	CARDINAL
dti-1410	42	3	9	CARDINAL
dti-1410	42	4	imai et al	PERSON
dti-1410	43	1	imai et al 30	PERSON
dti-1410	43	2	2015:9	CARDINAL
dti-1410	43	3	5	CARDINAL
dti-1410	43	4	5	CARDINAL
dti-1410	43	5	1	CARDINAL
dti-1410	44	1	around 65	CARDINAL
dti-1410	44	2	220 mg	QUANTITY
dti-1410	45	1	three months	DATE
dti-1410	45	2	6.1%	PERCENT
dti-1410	45	3	approximately 5 g/day	DATE
dti-1410	46	1	nephrotic syndrome.4	ORG
dti-1410	46	2	one	CARDINAL
dti-1410	47	1	level.1,6	ORG
dti-1410	47	2	reported.7,8	PERSON
dti-1410	48	1	analysis,10–12	PRODUCT
dti-1410	48	2	1	CARDINAL
dti-1410	50	1	day 12	DATE
dti-1410	50	2	300 mg	QUANTITY
dti-1410	50	3	day 16	DATE
dti-1410	53	1	31drug	CARDINAL
dti-1410	53	2	2015:9	CARDINAL
dti-1410	55	1	2	CARDINAL
dti-1410	57	1	henle	PRODUCT
dti-1410	58	1	daily	DATE
dti-1410	58	2	2	CARDINAL
dti-1410	58	3	between 107 ml	QUANTITY
dti-1410	58	4	470 ml	QUANTITY
dti-1410	59	1	ci	PERSON
dti-1410	62	1	1	CARDINAL
dti-1410	62	2	jf	PERSON
dti-1410	62	3	morales e	PERSON
dti-1410	62	4	tang w	PERSON
dti-1410	62	5	2	CARDINAL
dti-1410	64	1	2009;32(4	CARDINAL
dti-1410	64	2	650–657	CARDINAL
dti-1410	65	1	2	CARDINAL
dti-1410	65	2	onoyama	PERSON
dti-1410	66	1	fujishima	TIME
dti-1410	66	2	m. hemodynamic	PERSON
dti-1410	67	1	clin nephrol	PERSON
dti-1410	68	1	1987;27(1):21–25	CARDINAL
dti-1410	68	2	3	CARDINAL
dti-1410	68	3	davenport a. ultrafiltration	PERSON
dti-1410	70	1	2001	DATE
dti-1410	71	1	96(3–4):190–195	CARDINAL
dti-1410	71	2	4	CARDINAL
dti-1410	71	3	brater dc	PERSON
dti-1410	73	1	5	CARDINAL
dti-1410	73	2	vallon v	ORG
dti-1410	73	3	platt ka	PERSON
dti-1410	73	4	sglt2	GPE
dti-1410	75	1	2011;22(1):104–112	CARDINAL
dti-1410	76	1	6	CARDINAL
dti-1410	76	2	wright	PERSON
dti-1410	76	3	vallon v. probing	ORG
dti-1410	76	4	sglt2	PERSON
dti-1410	77	1	diab	PERSON
dti-1410	78	1	2015;12(2):78–89	CARDINAL
dti-1410	78	2	musso g	PERSON
dti-1410	78	3	gambino r	PERSON
dti-1410	78	4	pagano g.	PERSON
dti-1410	78	5	2	CARDINAL
dti-1410	79	1	ann med	PERSON
dti-1410	80	1	2012;44(4	CARDINAL
dti-1410	80	2	375–393	CARDINAL
dti-1410	81	1	8	CARDINAL
dti-1410	81	2	shah nk	PERSON
dti-1410	81	3	deeb	PERSON
dti-1410	81	4	epstein	PERSON
dti-1410	82	1	dapagliflozin	PERSON
dti-1410	82	2	2	CARDINAL
dti-1410	82	3	2	CARDINAL
dti-1410	84	1	2012;32(1):80–94	CARDINAL
dti-1410	84	2	9	CARDINAL
dti-1410	84	3	de zeeuw	PERSON
dti-1410	84	4	wie l	ORG
dti-1410	84	5	j. dapagliflozin	PERSON
dti-1410	84	6	2	CARDINAL
dti-1410	86	1	2013;15(9):853–862	CARDINAL
dti-1410	86	2	10	CARDINAL
dti-1410	86	3	komoroski	PERSON
dti-1410	86	4	feng y	PERSON
dti-1410	86	5	li l	PERSON
dti-1410	86	6	m. dapagliflozin	PERSON
dti-1410	86	7	sglt2	PERSON
dti-1410	86	8	2 weeks	DATE
dti-1410	86	9	2	CARDINAL
dti-1410	87	1	clin pharmacol	ORG
dti-1410	89	1	513–519	CARDINAL
dti-1410	90	1	11	CARDINAL
dti-1410	90	2	morrow l	DATE
dti-1410	90	3	28 days	DATE
dti-1410	90	4	2	CARDINAL
dti-1410	92	1	2012;14(6):539–545	CARDINAL
dti-1410	92	2	12	CARDINAL
dti-1410	93	1	rusch s	PERSON
dti-1410	93	2	wajs e.	PERSON
dti-1410	93	3	2	CARDINAL
dti-1410	94	1	clin	PERSON
dti-1410	95	1	2014;36(5):698–710	CARDINAL
dti-1410	95	2	13	CARDINAL
dti-1410	96	1	baker wl	PERSON
dti-1410	96	2	smyth lr	PERSON
dti-1410	96	3	riche dm	PERSON
dti-1410	96	4	bourret em	GPE
dti-1410	96	5	chamberlin kw	PERSON
dti-1410	96	6	white wb	PERSON
dti-1410	96	7	2	CARDINAL
dti-1410	97	1	j am soc hypertens	PERSON
dti-1410	98	1	2014;8(4):262–275	CARDINAL
dti-1410	98	2	14	CARDINAL
dti-1410	99	1	meltzer ji	PERSON
dti-1410	99	2	keim hj	PERSON
dti-1410	99	3	laragh jh	PERSON
dti-1410	99	4	sealey je	PERSON
dti-1410	99	5	jan km	PERSON
dti-1410	99	6	chien s. nephrotic	PERSON
dti-1410	100	1	ann intern med.	PERSON
dti-1410	101	1	1979;91(5):688–696	CARDINAL
dti-1410	101	2	15	CARDINAL
dti-1410	101	3	jp	ORG
dti-1410	101	4	norwood p	ORG
dti-1410	101	5	jf	PERSON
dti-1410	102	1	2	CARDINAL
dti-1410	104	1	2009;32(9):1656–1662	TIME
dti-1410	106	1	thomas mc	PERSON
dti-1410	108	1	2014;40	CARDINAL
dti-1410	108	2	6	CARDINAL
dti-1410	109	1	17	CARDINAL
dti-1410	109	2	jf	PERSON
dti-1410	109	3	whaley jm	PERSON
dti-1410	109	4	sglt2	GPE